Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, ...

A new review proposes an immunometabolic framework for paediatric refractory Mycoplasma pneumoniae pneumonia, while stressing ...

A seven-cohort single-cell atlas links early-onset colorectal cancer to coordinated epithelial, stromal and NOTCH-associated ...

Profiles Retro Biosciences, Altos Labs, NewLimit, Life Biosciences and Serina Therapeutics, covering their epigenetic reprogramming longevity therapies.Dublin, Oct. (GLOBE NEWSWIRE) -- "Epigenetic ...

The first humans are trying out cellular reprogramming for longevity. It looks like it might be working.

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

Players: Altos Labs, Retro Biosciences, NewLimit, Life Biosciences and Calico. The report profiles competitors, segments, regional presence, trends and opportunities.Dublin, Nov. 02, 2026 (GLOBE ...

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is ...

For those hoping to cure death, and they are legion, a 2016 experiment at the Salk Institute for Biological Studies in San Diego has become liminal — the moment that changed everything. The experiment ...

Researchers at PSI and ETH Zurich have taken connective tissue cells that have been mechanically reprogrammed to resemble stem cells and transplanted them into damaged skin. In their laboratory ...